Moreover, treatment of Pzp53med cells (derived from a mouse Ptc+/−/p53−/− tumor) with 10 nM roscovitine resulted in reduced levels of E2F1, FASN, Bmi1, cyclin D2, cdk2 and cdk4. The gene discussed is TP53; the disease is neoplasm.